We are live on ! Find out more
Delisted

NVRO was delisted on the 2nd of April, 2025.

201 hedge funds and large institutions have $2.4B invested in Nevro in 2017 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 88 increasing their positions, 46 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 46

17% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 41

16% more capital inflows, than outflows

Capital inflows: $662M | Capital outflows: $570M

7.79% more ownership

Funds ownership: 102.43% → 110.21% (+7.8%)

4% more funds holding

Funds holding: 193 → 201 (+8)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

25% less call options, than puts

Call options by funds: $14.7M | Put options by funds: $19.6M

Holders
201
Holders Change
+8
Holders Change %
+4.15%
% of All Funds
4.99%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.1%
New
48
Increased
88
Reduced
46
Closed
41
Calls
$14.7​M
Puts
$19.6​M
Net Calls
-⁠$4.91​M
Net Calls Change
-⁠$6.31​M

NVRO Hedge Fund Activity: Q2 2017 in Review

201 of the 4,025 institutional investors tracked by Wall St. Rank reported a position in Nevro (NVRO) for Q2 2017, worth a combined $2.4B — down 14% from $2.8B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new NVRO positions and 41 closed out — a net gain of 7 holders — while 88 added to existing stakes and 46 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $51.4M. The largest seller was Fidelity Investments, cutting an estimated $78.3M.

  • 201 institutional investors held Nevro (NVRO) as of Q2 2017, up from 193 in Q1 2017.
  • Funds reported $2.4B of Nevro stock for Q2 2017, down 14% quarter-over-quarter.
  • 48 funds opened new Nevro positions in Q2 2017 and 41 closed out, a net change of +7 holders.
  • The largest Nevro buyer in Q2 2017 was Citadel Advisors, an estimated $51.4M added.
  • The largest Nevro seller in Q2 2017 was Fidelity Investments, an estimated $78.3M sold.

Based on aggregated 13F filings for Q2 2017.